Lugade AA - Search Results

1

IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation.

Amobi-McCloud A, Muthuswamy R, Battaglia S, Yu H, Liu T, Wang J, Putluri V, Singh PK, Qian F, Huang RY, Putluri N, Tsuji T, Lugade AA, Liu S, Odunsi K. Amobi-McCloud A, et al. Among authors: lugade aa. Front Immunol. 2021 Apr 16;12:678999. doi: 10.3389/fimmu.2021.678999. eCollection 2021. Front Immunol. 2021. PMID: 34025677 Free PMC article.

2

The role of TLR2 and bacterial lipoprotein in enhancing airway inflammation and immunity.

Lugade AA, Bogner PN, Murphy TF, Thanavala Y. Lugade AA, et al. Front Immunol. 2011 Apr 27;2:10. doi: 10.3389/fimmu.2011.00010. eCollection 2011. Front Immunol. 2011. PMID: 22566801 Free PMC article.

3

NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer.

Szender JB, Papanicolau-Sengos A, Eng KH, Miliotto AJ, Lugade AA, Gnjatic S, Matsuzaki J, Morrison CD, Odunsi K. Szender JB, et al. Among authors: lugade aa. Gynecol Oncol. 2017 Jun;145(3):420-425. doi: 10.1016/j.ygyno.2017.03.509. Epub 2017 Apr 6. Gynecol Oncol. 2017. PMID: 28392127 Free PMC article.

4

Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study.

Grabosch S, Tseng G, Edwards RP, Lankes HA, Moore K, Odunsi K, Vlad A, Ma T, Strange M, Brozick J, Lugade A, Omilian A, Bshara W, Stuckey AR, Walker JL, Birrer M. Grabosch S, et al. Gynecol Oncol. 2017 Jul;146(1):137-145. doi: 10.1016/j.ygyno.2017.04.008. Epub 2017 May 5. Gynecol Oncol. 2017. PMID: 28483269 Free PMC article.

5

Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression.

Amobi A, Qian F, Lugade AA, Odunsi K. Amobi A, et al. Among authors: lugade aa. Adv Exp Med Biol. 2017;1036:129-144. doi: 10.1007/978-3-319-67577-0_9. Adv Exp Med Biol. 2017. PMID: 29275469 Review.

6

Nature of tumour rejection antigens in ovarian cancer.

Want MY, Lugade AA, Battaglia S, Odunsi K. Want MY, et al. Among authors: lugade aa. Immunology. 2018 Oct;155(2):202-210. doi: 10.1111/imm.12951. Epub 2018 Jun 13. Immunology. 2018. PMID: 29772069 Free PMC article. Review.

7

Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer.

Chodon T, Lugade AA, Battaglia S, Odunsi K. Chodon T, et al. Among authors: lugade aa. Hematol Oncol Clin North Am. 2018 Dec;32(6):1025-1039. doi: 10.1016/j.hoc.2018.07.011. Epub 2018 Oct 1. Hematol Oncol Clin North Am. 2018. PMID: 30390758 Free PMC article. Review.

8

Recombinant Sialyltransferase Infusion Mitigates Infection-Driven Acute Lung Inflammation.

Nasirikenari M, Lugade AA, Neelamegham S, Gao Z, Moremen KW, Bogner PN, Thanavala Y, Lau JTY. Nasirikenari M, et al. Among authors: lugade aa. Front Immunol. 2019 Feb 4;10:48. doi: 10.3389/fimmu.2019.00048. eCollection 2019. Front Immunol. 2019. PMID: 30778346 Free PMC article.

9

Metabolomic prediction of endometrial cancer.

Bahado-Singh RO, Lugade A, Field J, Al-Wahab Z, Han B, Mandal R, Bjorndahl TC, Turkoglu O, Graham SF, Wishart D, Odunsi K. Bahado-Singh RO, et al. Metabolomics. 2017 Dec 1;14(1):6. doi: 10.1007/s11306-017-1290-z. Metabolomics. 2017. PMID: 30830361

10

Neoantigens retention in patient derived xenograft models mediates autologous T cells activation in ovarian cancer.

Want MY, Konstorum A, Huang RY, Jain V, Matsueda S, Tsuji T, Lugade A, Odunsi K, Koya R, Battaglia S. Want MY, et al. Oncoimmunology. 2019 Mar 30;8(6):e1586042. doi: 10.1080/2162402X.2019.1586042. eCollection 2019. Oncoimmunology. 2019. PMID: 31069153 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page